AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone
Description: Induction 2: 0.1% QID; eye drops; days 1-6 Post consolidation course 2: 10 mg/m2/d; PO; days 1-28
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin
Description: Post consolidation: 25 mg/m2; IV; days 1, 8, 15, and 22
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leucovorin
Description: For CNS during induction: 5 mg every 6 hrs for 4 doses; PO; days 1, 4, 8, 11, etx.; after methotrexate if WBC \< 3,000
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mercaptopurine
Description: Consolidation: 60 mg/m2; PO; days 1-28 Post-consolidation course 1: 60 mg/m2/d; PO; days 1-63 Post-consolidation course 4: 60 mg/m2/d; PO; daily for 2 yrs
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methotrexate
Description: Consolidation: 12 mg; intrathecal or intraventricularly; days 2, 9, 16, and 23 Post-consolidation course 1: 20 mg/m2/wk; PO; days 1, 8 15, 22, 29, 36, 43, 50, 57 Post-consolidation course 4: 20 mg/m2; PO; weekly for 2 yrs
Study NCT04138810 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VCE
Description: Videoconference conducted according to a standard script which reviews the following key aspects of post-operative care: bowel functions, voiding functions, presence of vaginal bleeding, pain control, diet status, ambulatory status and any additional concerns. Standard post-operative instructions and precautions are reviewed as well.
Study NCT00193219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 5 mg/kg IV
Study NCT00193219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: 400 mg/m2 (first cycle only) IV on day 1 and 250 mg/m2 IV on day 8 with all subsequent cycles 250 mg/m2 IV on days 1 and 8
Study NCT00193219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Description: 400 mg/m2 bolus IV bolus followed by 2400 mg/m2 administered as continuous IV infusion over 46 hours via pump (outpatient)
Study NCT00193219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: 350 mg IV
Study NCT04138810 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey
Description: Measure of satisfaction regarding post-op visit.
Study NCT04138810 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey
Description: Measure of satisfaction regarding post-op visit.
Study NCT01500577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nimesulide
Description: Nimesulide 100 mg (capsules). 100mg/die every day for 1 year. Oral administration
Study NCT01500577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Simvastatin 20 mg (capsules). 20mg/die every day for 1 year. Oral administration
Study NCT01500577 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (capsules). 1 cps/die every day for 1 year. Oral administration
Study NCT02008760 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Omega Krill with D3
Study NCT03758001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI101
Description: 0.01 mg/kg; 0.1 mg/kg; 0.3 mg/kg; 1 mg/kg; 3 mg/kg; 6 mg/kg; 10 mg/kg; 15 mg/kg iv infusion day 1 of every 21 days
Study NCT00193219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 85 mg/m2 IV
Study NCT03758001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI101
Description: 1 mg/kg; 3 mg/kg; 6 mg/kg; 10 mg/kg iv infusion day 1 of every 21 days
Study NCT00360919 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cheese ingestion
Description: On study day 1, approximately half of the participants will consume a breakfast of fruits and vegetables, whereas the other half of participants will consume a meal consisting of 9 oz. of cheese.~Blood samples will be collected from participants immediately prior to consumption of the meals, and then again at regular intervals for up to 8 hours following the meals.~At least 3 days later, participants will return for study Day 2. The participants will receive the second meal. Blood samples will then be collected immediately prior to consumption of the test meal and for up to 8 hours after the meal.
Study NCT00360919 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: cheese ingestion
Description: On study day 1, approximately half of the participants will consume a breakfast of fruits and vegetables, whereas the other half of participants will consume a meal consisting of 9 oz. of cheese.~Blood samples will be collected from participants immediately prior to consumption of the meals, and then again at regular intervals for up to 8 hours following the meals.~At least 3 days later, participants will return for study Day 2. The participants will receive the second meal. Blood samples will then be collected immediately prior to consumption of the test meal and for up to 8 hours after the meal.
Study NCT03758001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg iv infusion day 1 of every 21 days
Study NCT01292811 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (Compex Motion Stimulator)
Description: Functional electrical Stimulation:Parameters of stimulation: 1) balanced, biphasic, current regulated electrical pulses; 2) pulse amplitude from 8 to 50 mA (typical values 17-26 mA); 3) pulse width from250 to 300 μs; and 4) pulse frequency from 20 to 70 Hz (typical value 25 to 40 Hz).
Study NCT02298478 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NO-FEAR Airlines
Description: NO-FEAR Airlines is a computer program that allows people who are afraid to fly to be exposed to images and sounds related to their phobic fears on a standard personal computer. The treatment can be totally self-applied.~NO-FEAR Airlines divides the flight process into six sequential stages: (1) flight preparation, (2) a series of activities immediately prior to flying on the day of the flight, (3) boarding and taking off, (4) the central part of the flight, (5) the airplane's descent, approach to the runway and landing, (6) sequence with images and auditory stimuli related to plane crashes.
Study NCT02298478 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: NO-FEAR Airlines
Description: NO-FEAR Airlines is a computer program that allows people who are afraid to fly to be exposed to images and sounds related to their phobic fears on a standard personal computer. The treatment can be totally self-applied.~NO-FEAR Airlines divides the flight process into six sequential stages: (1) flight preparation, (2) a series of activities immediately prior to flying on the day of the flight, (3) boarding and taking off, (4) the central part of the flight, (5) the airplane's descent, approach to the runway and landing, (6) sequence with images and auditory stimuli related to plane crashes.
Study NCT01292811 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Occupational therapy
Description: The Control group will receive conventional occupational therapy pertaining to hand function \[15\].~The conventional therapy represents control activities against which the FES therapy will be assessed. The conventional occupational therapy includes: a) muscle facilitation exercises emphasizing the neurodevelopmental treatment approach; b) task-specific, repetitive functional training; c) strengthening and motor control training using resistance to available arm motion to increase strength; d) stretching exercises; e) electrical stimulation applied primarily for muscle strengthening (this is not FES but TENS application); f) activities of daily living including self-care where the upper limb was used as an assist if appropriate; and g) caregiver training.
Study NCT02365831 — intervention group
Intervention type: OTHER
Intervention: Observation of treatment management
Description: Group/cohort
Study NCT01468363 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dry weight adjustment
Description: Dry weight adjustment according to BCM results
Study NCT01468363 — intervention group
Intervention type: DEVICE
Group type: NO_INTERVENTION
Intervention: Dry weight adjustment
Description: Dry weight adjustment according to BCM results
Study NCT01457469 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: questionnaire administration
Description: Ancillary studies
Study NCT01457469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Ancillary studies
Study NCT01457469 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: quality-of-life assessment
Description: Ancillary studies
Study NCT01457469 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: quality-of-life assessment
Description: Ancillary studies
Study NCT03360539 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership
Study NCT01457469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: counseling intervention
Description: Undergo counseling session
Study NCT01457469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: internet-based intervention
Description: Receive enhanced quitline intervention
Study NCT01457469 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: telephone-based intervention
Description: Receive enhanced quitline intervention
Study NCT01457469 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: educational intervention
Description: Receive usual care plus
Study NCT02847780 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Comparator :C-Mac Videolaryngoscope
Description: Real time assessment of Glottic aperture at the time of extubation by videolaryngoscope
Study NCT02847780 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator :C-Mac Videolaryngoscope
Description: Real time assessment of Glottic aperture at the time of extubation by videolaryngoscope
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mitoxantrone
Description: Induction 2: 80 mg/m2; IV; day 3
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asparaginase
Description: Induction: 2,000 IU/m2; IM or IV; day 15
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Induction: 60 mg/m2/d; PO or IV; days 1-35
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Post-consolidation course 3: 60 mg/m2/d; PO; days 1-14
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine
Description: Induction: 1.4 mg/m2/d (2 mg max); IV; days 1, 8, 15, 22
Study NCT00109837 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: For CNS during consolidation: cranial radiation after blasts are no longer present in spinal fluid. Total dose of 1800 cGy over 2 wks in 10 fractions of 180 cGy 5 days/wk.
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: allopurinol
Description: 300 mg/d PO Days 1-7
Study NCT00109837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bactrim
Description: 1 double strenth tablet 2x/d, 2x/wk, PO, begin with prednisone
Study NCT02014077 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: VATS ( Video-Assisted Thoracoscopy )
Description: the patients were randomized to a Video-Assisted thoracoscopy( VATS )for retained haemothorax
Study NCT02014077 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracostomy Tube reinsertion
Description: the patient is randomized to reinsertion of a Thoracostomy Tube for retained haemothorax
Study NCT01368627 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Supralimus® Sirolimus-Eluting Coronary Stent
Description: Supralimus® Coronary Stent System consisting of the MATRIX® Coronary Stent having Sirolimus eluting from Biodegradable Polymeric Matrix on a Stainless Steel Platform, Drug concentration 1.4 µg/mm2
Study NCT03896282 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mobilization at a dedicated daycare facility
Description: All THA's are performed using a standard posterolateral approach with simple posterior soft-tissue repair. No infiltration anesthesia (LIA) is used in THA's. All TKA's are performed with a standard medial parapatellar approach without the use of tourniquet. Physiotherapy is started as soon as possible after surgery in the dedicated day care facility. Time till first mobilization is recorded as is total time mobilized supervised by a physiotherapist before discharge.~Patients are discharged if fulfilling the discharge criteria before 8 pm. Number of hours spent in hospital in total is recorded.
Study NCT04975321 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nu Smile Zirconia crown
Description: Placement of an anterior primary crown restoration
Study NCT02847780 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: Airway ultrasound,
Description: Airway ultrasound using portable ultrasound machine to assess vocal cords movement.
Study NCT02847780 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Experimental: Airway ultrasound,
Description: Airway ultrasound using portable ultrasound machine to assess vocal cords movement.
Study NCT04826445 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Imaging collection
Study NCT02962141 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paclitaxel Releasing Peripheral Balloon Dilatation Catheter
Description: Treatment group
Study NCT02962141 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon Dilatation Catheter
Description: Control group
Study NCT03540381 — intervention group
Intervention type: OTHER
Intervention: neoatherosclerosis
Study NCT04528472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Treatment
Description: stimulate acupoints to accelerate recovery
Study NCT04528472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Regular Treatment
Description: Oral Medicine and Rehabilitation Treatment
Study NCT02886286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: Patient-activated intrathecal bolus for incident pain
Study NCT04975321 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nu Smile Pre Veneered crown
Description: Placement of an anterior primary crown restoration
Study NCT04975321 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Composite strip crown
Description: Placement of an anterior primary crown restoration
Study NCT03338179 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Judgement of learning evaluation
Description: The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.
Study NCT03338179 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Judgement of learning evaluation
Description: The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.
Study NCT00513552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifabutin, Clarithromycin, and Clofazimine
Description: Rifabutin 150 mg by mouth twice daily, Clarithromycin 250 mg by mouth twice a day, and Clofazimine 100 mg by mouth each morning
Study NCT02112721 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D
Study NCT02112721 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03329807 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: The subjects were seated in a comfortable chair with head and arm rests. Focal TMS of the somatosensory cortex was performed with a 70-mm figure-8 coil attached to magnetic stimulator stimulation parameters : frequency of 10Hz on the injured hemisphere by stroke; 1500 pulses with an intensity of 120% of MT 10 sessions of rTMS, one per day, always before conventional sensory therapy. rTMS it will be applied for about 20 minutes, five days per week.
Study NCT03329807 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: conventional sensory therapy
Description: Behavioral: conventional sensory therapy All patients will receive the same protocol of Sensory Therapy that will consist of the behavioral methods of Active Sensory Reeducation, Mirror Therapy and passive method that will consist in the administration of electric current by TENS (sensitive threshold). Participants will be instructed not to perform active muscular contraction during Interventions. The protocol it will be applied for about 60 minutes, five days per week.
Study NCT03329807 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: conventional sensory therapy
Description: Behavioral: conventional sensory therapy All patients will receive the same protocol of Sensory Therapy that will consist of the behavioral methods of Active Sensory Reeducation, Mirror Therapy and passive method that will consist in the administration of electric current by TENS (sensitive threshold). Participants will be instructed not to perform active muscular contraction during Interventions. The protocol it will be applied for about 60 minutes, five days per week.
Study NCT01010126 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT01010126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temsirolimus
Description: Given IV
Study NCT04439084 — intervention group
Intervention type: OTHER
Intervention: Prospective Chart Review
Description: Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.
Study NCT04236583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telehealth
Description: Post-discharge virtual visit
Study NCT03307564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TraceIT tissue marker injection
Description: The TraceIT injection will be performed during the endoscopic fiducial placement which is the standard of care. CTs to serially confirm TraceIT positioning will be performed on the same day during patient visits for their middle (2nd or 3rd fraction) and last (5th fraction) radiation therapy treatments.
Study NCT03765086 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Karydakis procedure
Description: Pilonidal sinus will be excised by Karydakis procedure
Study NCT03765086 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Limberg Flap
Description: Pilonidal sinus will be excised by Limberg Flap
Study NCT02886286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opioid
Description: Patient-activated intrathecal bolus for incident pain
Study NCT02886286 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opioid
Description: Patient-activated intrathecal bolus for incident pain
Study NCT02205320 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim Form A
Study NCT02205320 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim Form B
Study NCT02128737 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep
Study NCT02009826 — intervention group
Intervention type: RADIATION
Intervention: [18F]-PBR111 Positron Emission Tomography (PET)
Description: \[18F\]-PBR111 radioligand to assess binding to TSPO
Study NCT00921037 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erbium-YAG laser vaporization
Description: spot size 2-5 mm diameter, applying about 1,2 -2 J at a frequency of 6-12 Hz
Study NCT02009826 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cognitive and psychomotor tasks
Description: Cognitive and psychomotor tasks on digitizing tablet
Study NCT02009826 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling
Description: Blood sampling for peripheral inflammatory and neurotoxicity markers
Study NCT05364398 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction
Description: Use of hamstring tendons graft to replace the torn ACL and being passed and fixed through the femoral and tibial sides
Study NCT03708367 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LipiFlow Thermal Pulsation System
Description: Treatment at preoperative visit for study group
Study NCT03708367 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: LipiFlow Thermal Pulsation System
Description: Treatment at 3 month visit as the cross-over group
Study NCT02441894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CABAZITAXEL XRP6258
Description: Pharmaceutical form:solution Route of administration: intravenous
Study NCT02441894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEG-G-CSF
Description: Pharmaceutical form:solution Route of administration: subcutaneous
Study NCT02441894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Pharmaceutical form:tablet Route of administration: oral
Study NCT02441894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexchlorpheniramine or Diphenhydramine
Description: Pharmaceutical form:tablet, powder, or solution Route of administration: oral, intravenous or intramuscular